CJ
Chetna Jain
About Chetna Jain
Data last updated:
Chetna Jain is a Director at Neocell Bio-Technologies Private Limited (since 2024), Director at Dandu Biosciences Private Limited (since 2025) and Director at Enneva Therapeutics Private Limited (since 2024). The companies operate in Pharma and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹12.64 Cr; the largest is Neocell Bio-Technologies Private Limited at ₹11.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neocell Bio-Technologies Private Limited U21001TS2023PTC179295 | Director | 04 Jul 2024 | 2023 | ₹11.75 Cr (FY 2025) | Active |
 Dandu Biosciences Private Limited U24290TG2021PTC156859 | Director | 20 Jan 2025 | 2021 | ₹89.1 Lakh (FY 2025) | Active |
| Enneva Therapeutics Private Limited U24299TG2021PTC156857 | Director | 21 Sep 2024 | 2021 | Active |
Board colleagues of Chetna Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jeetendra Ambulge Kashinath | 07822881 | Neocell Bio-Technologies Private Limited , Dandu Biosciences Private Limited and 1 more | Managing Director |
| Prashant Somayaji Tangirala | 09691325 | Neocell Bio-Technologies Private Limited | Director |
| Sree Ramachandra Murthy Musti | 08972267 | Neocell Bio-Technologies Private Limited | Director |
| Ashwini Mangalampalle | Dandu Biosciences Private Limited | Company Secretary | |
| Joyeeta Nair | 10821341 | Dandu Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetna Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetna Jain
Chetna Jain currently holds 3 directorships: Neocell Bio-Technologies Private Limited (Director, since 04 Jul 2024, revenue ₹11.75 Cr (FY 2025)); Dandu Biosciences Private Limited (Director, since 20 Jan 2025, revenue ₹89.1 Lakh (FY 2025)); Enneva Therapeutics Private Limited (Director, since 21 Sep 2024).
Chetna Jain was first appointed on 04 Jul 2024 as Director at Neocell Bio-Technologies Private Limited. The most recent appointment on record is 20 Jan 2025 at Dandu Biosciences Private Limited.
The 2 current companies of Chetna Jain that report revenue have a combined latest revenue of ₹12.64 Cr: Neocell Bio-Technologies Private Limited ₹11.75 Cr (FY 2025); Dandu Biosciences Private Limited ₹89.1 Lakh (FY 2025).
The current boards of Chetna Jain's companies include Jeetendra Ambulge Kashinath (Neocell Bio-Technologies Private Limited), Prashant Somayaji Tangirala (Neocell Bio-Technologies Private Limited), Sree Ramachandra Murthy Musti (Neocell Bio-Technologies Private Limited), Ashwini Mangalampalle (Dandu Biosciences Private Limited), Joyeeta Nair (Dandu Biosciences Private Limited).